Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The amygdala hyperactivation, excessive sympathetic nervous system arousal, and impaired fear extinction that characterize anxiety disorders respond to different peptide targets than the anhedonia, BDNF deficits, and hippocampal atrophy more central to depression
Used correctly, the weight lost during the Phentermine period becomes the foundation for sustained long-term results
Once the therapy begins, the clinic prioritizes ongoing monitoring and support
Several areas warrant medical oversight
Technical Specifications Compound: BPC-157 (Synthetic Pentadecapeptide) Format: Lyophilized peptide powder Strength: 10 mg per vial Purity: 9899% (COA included) Appearance: White lyophilized powder Category: Research peptide reagent Intended Use This product is intended strictly for: Laboratory experimentation In-vitro scientific research Biochemical and molecular studies Non-human preclinical model development Institutional or academic research programs Not intended for: Human or animal consumption Injection, ingestion, inhalation, or topical use Medical, therapeutic, diagnostic, or cosmetic purposes This compound is not approved by Health Canada, FDA, or any regulatory authority for clinical use
In consideration of the comments received related to concerns about low response rates and survey fatigue, we are not adopting the Information Transfer PRO-PM at this time
US$ 28.54
US$ 23.54
US$ 24.59
US$ 20.89
